Physician

Sashi Naidu, M.D.

According to 2025 Medicare claims, Sashi Naidu, M.D. (NPI: 1245327279) practices internal medicine in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from York, SC. This provider's primary affiliated billing organization is CAROLINA BLOOD AND CANCER CARE ASSOCIATES, P.A. (NPI: 1013002013; TIN: 35-2221941) and primary practice location at 29732-3858.

Naidu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 443 traditional Medicare patients, billed 40,456 HCPCS/CPT codes, and received $720,391 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 867 prescription claims across 142 beneficiaries totaling $2,729,734 in drug costs, led by Ninlaro (Ixazomib Citrate). 2022 DME data shows 13 claims. Open Payments data shows 160 records totaling $42,523. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $832,150 and ending at $720,391. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $452,188 to $2,729,734. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	409	71,365	$832,150
2016	491	118,590	$998,637
2017	533	139,670	$1,178,975
2018	574	139,773	$1,405,528
2019	510	89,967	$1,157,819
2020	402	62,029	$812,535
2021	423	94,232	$1,261,175
2022	432	101,622	$1,184,067
2023	471	67,701	$1,057,394
2024	443	40,456	$720,391

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	122	769	$452,188
2016	137	800	$641,145
2017	139	736	$509,369
2018	154	852	$799,913
2019	143	797	$1,197,229
2020	122	711	$1,337,839
2021	139	820	$2,332,515
2022	137	761	$2,263,123
2023	140	794	$2,385,122
2024	142	867	$2,729,734

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$407
2017	N/R	N/R	N/R
2018	N/R	17	$4,633
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	13	$750
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	292	773	$57
99497	Advance care planning, first 30 minutes	195	250	$51
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	150	688	$41
36415	Insertion of needle into vein for collection of blood sample	240	700	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	347	959	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ninlaro	Ixazomib Citrate	37	1,036	$445,004
Ibrance	Palbociclib	22	609	$321,630
Cabometyx	Cabozantinib S-Malate	11	330	$275,091
Jakafi	Ruxolitinib Phosphate	11	330	$185,803
Brukinsa	Zanubrutinib	12	360	$159,892

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	154	$5,927	SOBI, INC
Research Payments	Reported research-related payment or transfer-of-value amount.	6	$36,595	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sashi Naidu, M.D.?

Tedicare shows public-source Medicare data for Sashi Naidu, M.D. (NPI 1245327279), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sashi Naidu, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sashi Naidu, M.D.?

Sashi Naidu, M.D. is linked to CAROLINA BLOOD AND CANCER CARE ASSOCIATES, P.A. (billing NPI 1013002013) in the available physician profile data.

Does Sashi Naidu, M.D. have Open Payments data?

Sashi Naidu, M.D. has 160 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.